CompletedPhase 2ketamine

EEG Studies of Sevoflurane-Induced General Anesthesia

Sponsored by Massachusetts General Hospital

NCT ID
NCT03503578
Target Enrollment
12 participants
Start Date
2018-05-01
Est. Completion
2018-08-01

About This Study

The investigators are performing this research study to find out how and where the anesthetic drugs sevoflurane and ketamine act in the brain. Sevoflurane and ketamine are anesthetics (a drug or agent used to decrease or eliminate the feeling of pain by causing unconsciousness). The investigators will study the brain using a machine that records the brain's electrical activity, called an electroencephalogram (EEG).

Conditions Studied

Anesthesia

Interventions

  • Sevoflurane
  • Ketamine

Eligibility

Age:18 Years - 50 Years
Healthy Volunteers:Yes
View full eligibility criteria
Inclusion Criteria:

* Between the ages of 18 and 50
* Normal body weight and habitus, BMI ≤ 30
* Non-smoker
* American Society of Anesthesiologists (ASA) physical status classification P1

Exclusion Criteria:

* Chronic health conditions

Study Locations (1)

Massachusetts General Hospital
Boston, Massachusetts, United States

This trial is not recruiting

This study has completed enrollment. Check back for results or find similar trials.

Find recruiting trials
Data Source
ClinicalTrials.gov

Last updated from source